| Net loss | -11.31M |
| Depreciation and amortization expense | 772K |
| Bad debt expense | 169K |
| Amortization of debt discount | 0 |
| Transaction compensation expense - warrants | 3.9M |
| Other - inadequate reserves of common stock | 1.74M |
| Loss on sale of property and equipment | 0 |
| Currency translation loss (gain) | 1.81M |
| Change in fair value of warrant liability | -14K |
| Inventories | 126K |
| Accounts receivable | 261K |
| Prepaid expenses and other assets | -82K |
| Accounts payable and accrued expenses | -303K |
| Net cash used in operating activities | -2.93M |
| Capital Expenditures | -29K |
| Net cash used in investing activities | -29K |
| Repayment of debt | -210K |
| Proceeds from loans from related parties | 0 |
| Proceeds from issuance of convertible debt | 371K |
| Proceeds from equity issuance | 3M |
| Net cash provided by financing activities | 3.16M |
| CURRENCY EFFECTS ON CASH AND CASH EQUIVALENTS | -107K |
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 97K |
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 927K |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | 1.02M |
| Interest paid (Silent Partnership Loans - TBG) | 0 |
| Income taxes paid | 0 |